Sunshine Biopharma, Inc. Board of Directors

Sunshine Biopharma, Inc., a pharmaceutical company, focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. It operates in two segments, Prescription Generic Pharmaceuticals and Nonprescription Over-The-Counter Products. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; Adva-27a, a small chemotherapy molecule to treat pancreatic cancer; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, and anticonvulsant indications. Sunshine Biopharma, Inc. is based in Fort Lauderdale, Florida.

Dr. Steve N. Slilaty Ph.D.

Dr. Steve N. Slilaty Ph.D.

Chairman, President & CEO

Mr. Michel Roy

Mr. Michel Roy

Chief Commercial Officer

Dr. Abderrazzak Merzouki

Dr. Abderrazzak Merzouki

Chief Science Officer & Director

Mr. Malek Chamoun

Mr. Malek Chamoun

Chief Development Officer

Mr. Robert G. Ferreira

Mr. Robert G. Ferreira

President of Sunshine Bio Investments Inc

Leaving Board of Directors Review Your about to visit the following url Invalid URL

Loading...
Comments


Comment created.